Access cutting-edge hiv prevention treatment through this clinical trial at a research site in Washington Dc. Study-provided care at no cost to qualified participants.
Access hiv prevention specialists in Washington Dc at no cost
This study follows strict safety protocols and ethical guidelines
All study-related hiv prevention treatment provided free
Researchers are looking for new medicines to prevent HIV-1 (Human Immunodeficiency Virus Type 1) infection. The goals of this study are to learn: * If taking MK-8527 once a month works to prevent HIV-1 infection as well as or better than a standard (usual) pre-exposure prophylaxis (PrEP) taken once a day * About the safety of MK-8527 and if people tolerate it
Sponsor: Merck Sharp & Dohme LLC
Check if you qualify for this hiv prevention clinical trial in Washington Dc, DC
If you're searching for hiv prevention treatment options in Washington Dc, DC, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Washington Dc research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hiv prevention specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.